| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 131.231 | 160.725 | 157.440 | 147.598 | 173.590 | 165.430 | 225.160 | 245.472 | 296.878 | 306.050 |
| Total Income - EUR | 131.233 | 161.300 | 157.442 | 153.649 | 179.270 | 175.200 | 225.167 | 245.475 | 296.882 | 306.054 |
| Total Expenses - EUR | 121.983 | 139.504 | 136.390 | 137.559 | 173.091 | 167.499 | 177.809 | 201.284 | 224.902 | 288.554 |
| Gross Profit/Loss - EUR | 9.250 | 21.795 | 21.052 | 16.090 | 6.179 | 7.701 | 47.358 | 44.191 | 71.981 | 17.501 |
| Net Profit/Loss - EUR | 7.761 | 18.212 | 18.953 | 14.554 | 4.438 | 6.364 | 45.151 | 41.786 | 69.564 | 8.502 |
| Employees | 8 | 9 | 8 | 8 | 8 | 10 | 10 | 10 | 9 | 9 |
Check the financial reports for the company - Biomed Doris Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 39.777 | 36.498 | 30.856 | 51.614 | 79.447 | 60.193 | 41.044 | 55.990 | 57.641 | 63.223 |
| Current Assets | 22.547 | 31.631 | 42.757 | 41.396 | 35.455 | 55.726 | 93.998 | 127.906 | 78.306 | 50.405 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 17.524 | 23.383 | 18.061 | 26.026 | 20.167 | 10.982 | 24.451 | 18.039 | 47.026 | 16.640 |
| Cash | 5.023 | 8.248 | 24.696 | 15.370 | 15.288 | 44.744 | 69.547 | 109.867 | 31.280 | 33.765 |
| Shareholders Funds | 36.444 | 54.284 | 63.679 | 58.459 | 61.766 | 66.959 | 100.146 | 53.020 | 88.055 | 18.466 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 26.658 | 14.614 | 9.934 | 34.550 | 53.136 | 48.960 | 34.896 | 135.064 | 51.936 | 95.678 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Biomed Doris Srl